CPhI Global Events
Ingredients & Formulation
Manufacturing & Outsourcing
Packaging & Drug Delivery
Middle East & Africa
Chinese API producers shielded from medium-term pain despite COVID-19-related market rebalancing: Fitch Ratings
May 26, 2020
Reducing dependence on China would increase production costs for generic drug makers, analysts say
US government signs $354 million generics and API manufacturing contract with Phlow
May 19, 2020
Pharma start-up will use continuous manufacturing to shore up supply chain of essential medicines
Gilead signs agreements with generics firms to manufacture and market remdesivir
May 13, 2020
Voluntary licensing deals allow firms to distribute drug recently granted FDA EUA to treat patients with COVID...
CPhI Webinar Series - Pharma Action Against COVID-19 – Listen Now
May 11, 2020
Listen to recordings of all webinars broadcast during the week of May 04-08
Is COVID-19 the catalyst for Western pharma markets to revert to domestic API production?
May 07, 2020
The ongoing pandemic has fuelled debate about whether Western pharmaceutical supply chains and API sourcing are too dependent on lower-cost Asian suppliers such as China. Do the US and Europe need to bring manufacturing back home?
Evonik launches European API manufacturing capacity expansion programme
May 06, 2020
EUR 25 million first stage expected to be completed by mid-2021 as COVID-19 pandemic highlights need for more European capacity
Strides starts exports of generic version of Avigan for COVID-19 treatment
Apr 29, 2020
Antiviral drug has been developed in-house with API manufacturer signed up to secure KSM
Nitrosamine contamination: pharma’s re-evaluation of its supply chain
Apr 17, 2020
The detection of nitrosamine impurities in some finished dosages has opened up a whole new set of challenges for API...
Lupin receives FDA all-clear for Mandideep API manufacturing facility
Apr 15, 2020
Company becomes the fourth Indian pharma firm to secure FDA clearance in the last two weeks
The Future of Drug Manufacturing
Mar 23, 2020
As biopharma manufacturing requirements shift and evolve, technologies such as digitization, automation and AI all come very...
Global API Snapshot: Pharma Demands and Evolving Markets
Mar 22, 2020
Fierce competition in the low cost, high volume API sector is forcing suppliers to invest in capacity and accelerate throughout.
Indian pharma supply chain disruption to surpass 2017 if COVID-19 not contained: Ind-Ra
Mar 13, 2020
India's pharma industry's resilience to the effects of coronavirus will be severely tested the longer the global pandemic persists, says credit rating agency
API Demands & Evolving Markets
Mar 09, 2020
API production is a global business, with supply chains around the world being shaped by shifting industry demand. Price & regulatory compliance is among the most important drivers of change.